Prescient Therapeutics LimitedASX: PTX

US Patent Granted for PTX-200 for Ovarian Cancer Treatment

Jul 26, 2018 at 3:19 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment